rf-fullcolor.png

 

July 17, 2012
by Louise Zornoza

Breaking: European Commission Adopts Proposal for a 'Clinical Trials Regulation'

The European Commission has issued a proposal to revamp the rules governing clinical trials.   The proposed legislation will replace the "Clinical Trials Directive" of 2001, and will take the form of a regulation, ensuring that the rules for conducting clinical trials are identical throughout the EU. 

In particular, it will make it easier to conduct multinational clinical trials in Europe. Some concrete proposals are:

  • An authorization procedure for clinical trials, which will allow for a fast and thorough assessment of the application by all Member States concerned, and which will ensure one single assessment outcome.
  • Simplified reporting procedures, which will spare researchers from submitting largely identical information on the clinical trial separately to various bodies and Member States.
  • More transparency on whether recruitment for participating in a clinical trial is still ongoing, and on the results of the clinical trial.
  • The possibility for the Commission to conduct controls in Member States and other countries to make sure the rules are being properly supervised and enforced.

The legislative proposal will now be discussed in the European Parliament and in the Council. It is expected to come into effect in 2016.

Read more:

Revision of the Clinical trials Directive

Read more Breaking News from RegLink

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.